SNCA and Parkinson disease: As further discussed in the “Introduction” section, both clinical and experimental evidence of pathological α-synuclein lesions in the gut support the hypothesis that gut-to-brain and/or brain-to-gut pathways of α-synuclein spreading may play a role in PD pathogenetic processes [7, 8, 63, 64].